| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |